Amphastar Pharmaceuticals (AMPH) Change in Intangibles (2017 - 2018)
Amphastar Pharmaceuticals (AMPH) posted quarterly Change in Intangibles of $4.4 million for Q1 2018, up 340.0% year-over-year from $1000000.0 in Q1 2017, and up 340.0% quarter-over-quarter from $1.0 million in Q3 2017.
Amphastar Pharmaceuticals (AMPH) Change in Intangibles (2017 - 2018) Analysis & Trends
Amphastar Pharmaceuticals' Change in Intangibles history runs 2 years deep, the most recent figure standing at $4.4 million for Q1 2018.
- In Q1 2018, Change in Intangibles rose 340.0% year-over-year to $4.4 million; the TTM figure through Dec 2018 stood at $4.4 million (up 46.67% YoY), while the FY2018 annual figure was $4.4 million, up 120.0% from the prior year.
- Change in Intangibles for Q1 2018 stood at $4.4 million, up from $1.0 million in the prior quarter.
- The five-year high for Change in Intangibles was $4.4 million in Q1 2018, with the low at $1.0 million in Q1 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | -310.09 Mn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 944.46 Mn | 654.33 Mn | 93.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 4.40 Mn |
| Mar 31, 2018 | 4.40 Mn |
| Sep 30, 2017 | 1.00 Mn |
| Sep 30, 2017 | 1.00 Mn |
| Jun 30, 2017 | 1.00 Mn |
| Jun 30, 2017 | 1.00 Mn |
| Mar 31, 2017 | 1.00 Mn |
| Mar 31, 2017 | 1.00 Mn |